Elon Musk’s Tesla Remains One of the Last Great Founder-Led Tech Giants. Is the Stock a Buy Before July 22?
Key Points Great companies are often launched by great leaders — but often they don’t stay that way. Larry Page ...
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway
uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets ...
5 “Magnificent Seven” Stocks I’m Buying and 2 That I’m Selling
Key Points The “Magnificent Seven” is a group of stocks that make up the largest companies in the world. Their ...
The 3 Biggest Bargain “Magnificent Seven” Stocks to Buy Today
Key Points Nvidia is the cheapest “Magnificent Seven” stock despite having the strongest revenue growth. Meta Platforms has a great ...
What Do SpaceX, AMD, and Palantir Have in Common?
Key Points Space Exploration Technologies (NASDAQ: SPCX), AMD (NASDAQ: AMD), and Palantir Technologies (NASDAQ: PLTR) may seem like an odd ...
Crypto Market Update: Circle Surges After Securing Federal Trust Bank Charter
Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrencymarket news Here’s a quick ...
How Buying SpaceX Today Could More Than 10X Your Net Worth
Key Points SpaceX’s 2025 revenue was $18.7 billion, but one prediction sees annual revenue rising to $3.4 trillion in 2040. ...
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix
uniQure N.V. QURE now represents more than a single-program gene therapy story. Its profile is being reshaped by faster regulatory ...
The Chip Index Just Fell Into a Bear Market. Apple Is Sitting Near an All-Time High Anyway.
Key Points The PHLX Semiconductor Index closed in a bear market on Friday, more than 20% below its June peak. ...
Friday’s ETF with Unusual Volume: FFLG
The Fidelity Fundamental Large Cap Growth ETF is seeing unusually high volume in afternoon trading Friday, with over 2.0 million ...
